Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders

摘要

Disclosed is the use of 3-{6-[(4-chlorophenylsulphonyl)amino]-1-methyl-5,6,7,8-tetrahydronaphth-1-yl}propionic acid of formula (I) in the form of an optical isomer or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of vascular disorders in patients having had a previous cerebral vascular accident.